LIMERICK, Pa.--(BUSINESS WIRE)--Aug. 26, 2013--
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical
devices for critical care and surgery, will showcase its regional
anesthesia and pain management products featuring improved practices
during the ESRA Congress in Glasgow, UK, on September 4-7, 2013.
At the ESRA, September 4-7, Teleflex will highlight its diversified
range of regional anesthesia and pain management products. The Company
will place particular attention upon its newly designed FlexBlockTM
catheterization sets, UltraQuikTM peripheral nerve block
needles and the ambIT® PCA pump.
The FlexBlockTM catheterization sets provide clinicians with
an echogenic stimulating / non-stimulating needle and the option of
ultrasound techniques. The FlexBlock catheter’s unique design offers a
combination of ultrasound visibility, flexibility, excellent
kink-resistance and a catheter tip that is designed to provide a
predictable spread of anesthetic.
Arrow brand clinician inspired UltraQuikperipheral nerve
block needles are designed to help increase overall block success when
performing single-shot peripheral nerve blocks using ultrasound. To make
it as straightforward as possible to identify the needle under
ultrasound, the distal end of the needle cannula has five grooved rings.
The ambIT PCA pump ambulatory pain control systems for post-operative
pain management from Summit provide flexible, accurate and safe
therapy-specific configurations at the lowest cost-in use.
About Teleflex Incorporated
Teleflex is a leading global provider of specialty medical devices for a
range of procedures in critical care, urology and surgery. Our mission
is to provide solutions that enable healthcare providers to improve
outcomes and enhance patient and provider safety. Headquartered in
Limerick, PA, Teleflex employs approximately 11,500 people worldwide and
serves healthcare providers in more than 140 countries. Additional
information about Teleflex can be obtained from the company's website at teleflex.com.
Forward-Looking Statements
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report
on Form 10-K.
FlexBlock and UltraQuik are trademarks or registered trademarks of
Teleflex Incorporated or its affiliates. ©2013 Teleflex Incorporated.
All rights reserved.
ambIT® is a trademark of Summit Medical Products, Inc. All rights
reserved.
Source: Teleflex Incorporated
Teleflex Incorporated
Jake Elguicze
Treasurer and Vice
President, Investor Relations
610-948-2836
or
Martina
Teichmann-Zindler
Director Marketing Communications International
+49
(0)7151-406-538
martina.teichmann@teleflex.com